Investor Presentation • Aug 12, 2024
Investor Presentation
Open in ViewerOpens in native device viewer


This document contains forward looking statements which reflect the Board of Directors' current views and estimates. The forward-looking statements involve certain risks and uncertainties that could cause actual results to differ materially from those contained in the forward-looking statements. Potential risks and uncertainties include such factors as general economic conditions, foreign exchange fluctuations, competitive product and pricing pressures, the effects of a pandemic or epidemic or a natural disaster, or war and regulatory developments.
You are cautioned not to place undue reliance on any forward-looking statements. These forward-looking statements are made as of the date of this document. The Company expressly disclaims any obligation or undertaking to publicly update or revise any forward-looking statements other than as required by applicable law.









New capacity coming on stream to leverage consumer trends:













1.) Represents 6-month financial period ended June 2023
2.) ROIC is calculated as per the definition outlined in glossary on slide 38


1.) Represents 6-month financial period ended June 2023


| H1 FY24 | H1 FY231.) | Var. vs. PY | |
|---|---|---|---|
| Organic Growth | (1.1)% | 22.9% | (2400)bps |
| EBITDA % | 13.6% | 12.2% | +140bps |
Revenue:
Innovation acceleration from 10.0% to 18.9% of revenue


| H1 FY24 | H1 FY231.) | Var. vs. PY | |
|---|---|---|---|
| Organic Growth | 2.8% | 15.8% | (1300)bps |
| EBITDA % | 18.7% | 21.2% | (250)bps |
Revenue:
Resilient growth across channels pricing and innovation

In €m / % of revenue


| Levers | Mid-Term Targets 2023-25 | H1 FY24 Results | ||
|---|---|---|---|---|
| Manufacturing continuous improvement program |
2-3% cost1.) efficiency YoY | ▪ | Manufacturing efficiency: | on track |
| SIMPLEX – recipe standardisation & Procurement leverage |
€26-36m costs optimisation | ▪ | Costs optimisation: | > €28m |
| E2E processes optimisation | Fixed costs growth @ 30-40% of organic growth |
▪ | Fixed cost growth: | above - driven by higher labour costs |
1.) Costs baseline: Conversion Costs (indirect variable & fixed manufacturing costs incl. Deprecation) + Waste

Free cash flow evolution (in €m)


Trade Working Capital as % of TTM revenue1.)

trade payables
2.) Quarters correspond to financial periods aligned with calendar year (based on pro-forma information)

1.) Represents 6-month financial period ended June 2023

-4
-2
0
2
4
6
8




ROIC acceleration driven by:
1.) ROIC is calculated as per the definition outlined in glossary on slide 38



Our strategy is delivering:
→ Well on track to deliver last remaining mid-term target







| H1 FY24 | H1 FY231). | ||
|---|---|---|---|
| € m |
€ m |
Change % | |
| Revenue | 1,055.2 | 1,060.2 | (0.5)% |
| Cost of sales | (691.8) | (726.3) | 4.8% |
| Distribution expenses | (138.8) | (132.7) | (4.6)% |
| Gross profit | 224.6 | 201.2 | 11.6% |
| Selling expenses | (50.0) | (45.7) | (9.4)% |
| Administration expenses | (89.0) | (79.4) | (12.1)% |
| Operating profit | 85.6 | 76.1 | 12.5% |
| Financing costs, net | (16.1) | (13.0) | (23.8)% |
| Profit before income tax | 69.5 | 63.1 | 10.1% |
| Income tax expense | (11.4) | (5.1) | (123.5)% |
| Profit for the period | 58.1 | 58.0 | 0.2% |
| Hybrid dividend | (17.4) | (22.8) | 23.7% |
| Profit used to determine EPS | 40.7 | 35.2 | 15.6% |
| Weighted average shares (in millions) | 996.6 | 994.9 | 0.2% |
| Diluted earnings per share (in € cent) | 4.1 | 3.5 | 17.1% |

| ARYZTA | ARYZTA | ||
|---|---|---|---|
| Europe | Rest of World | Total Group | |
| €m | €m | €m | |
| Revenue | 937.9 | 117.3 | 1,055.2 |
| Organic growth | (1.1%) | 2.8% | (0.7%) |
| Currency movement | 0.8% | (4.5%) | 0.2% |
| Total revenue movement | (0.3%) | (1.7%) | (0.5%) |

| H1 FY24 | H1 FY231). | ||
|---|---|---|---|
| €m | €m | % change | |
| ARYZTA Europe | 127.9 | 114.7 | 11.5% |
| ARYZTA Rest of World | 21.9 | 25.3 | (13.4%) |
| Total Group | 149.8 | 140.0 | 7.0% |
| H1 FY24 | H1 FY23 | Change | |
| €m | €m | bps | |
| ARYZTA Europe | 13.6% | 12.2% | 140 bps |
| ARYZTA Rest of World | 18.7% | 21.2% | (250) bps |
| Total Group | 14.2% | 13.2% | 100 bps |
1). Represents 6-month financial period ended June 2023
2). See glossary on slide 38 for definitions of financial terms and references

| H1 FY24 | H1 FY231). | |
|---|---|---|
| €m | €m | |
| EBITDA | 149.8 | 140.0 |
| Working capital movement | 2.9 | 18.4 |
| Working capital movement from debtor securitisation | 2.9 | 13.3 |
| Capital expenditure | (41.6) | (28.8) |
| Net payments on lease contracts | (18.2) | (17.9) |
| Proceeds from sale of property, plant and equipment | 0.3 | 2.9 |
| Restructuring-related cash flows | (0.3) | (1.3) |
| Dividends paid on hybrid instruments | (17.7) | (32.8) |
| Interest and income tax on operating activities paid, net | (27.8) | (20.0) |
| Other | 2.7 | (1.7) |
| Free cash flow | 53.0 | 72.1 |

| H1 FY24 | FY23 | H1 FY231). | |
|---|---|---|---|
| €m | €m | €m | |
| Average invested capital | 1,197.2 | 1,225.3 | 1,231.9 |
| NOPAT2). | 156.7 | 150.1 | 124.2 |
| ROIC2). | 13.1% | 12.3% | 10.1% |
1.) Represents 6-month financial period ended June 2023
2.) See glossary on slide 38 for definitions of financial terms and references

| H1 FY24 | FY23 | H1 FY231). | ||
|---|---|---|---|---|
| €m | €m | €m | ||
| Net debt | 432.2 | 490.8 | 409.9 | |
| Hybrid Instrument Funding | 494.6 | 510.0 | 608.4 | |
| Total net debt and hybrid funding | 926.8 | 1,000.8 | 1,018.2 |

| Q3 20231). | Q4 20231). | Q1 2024 | Q2 2024 | H1 FY24 | |
|---|---|---|---|---|---|
| ARYZTA Europe | |||||
| Volume % | 0.3% | 5.6% | 0.8% | (0.7)% | 0.1% |
| Price % | 10.4% | 3.6% | - | (1.6)% | (0.9)% |
| Mix % | (1.7)% | (0.6)% | (0.5)% | (0.2)% | (0.3)% |
| Organic growth % | 9.0% | 8.6% | 0.3% | (2.5)% | (1.1)% |
| ARYZTA Rest of World | |||||
| Volume % | 3.8% | 0.4% | (4.2)% | 4.2% | (0.1)% |
| Price % | 7.5% | 5.8% | 2.7% | 2.8% | 2.8% |
| Mix % | (1.2)% | (1.3)% | 0.2% | - | 0.1% |
| Organic growth % | 10.1% | 4.9% | (1.3)% | 7.0% | 2.8% |
| Total Group | |||||
| Volume % | 0.8% | 5.0% | 0.2% | (0.2)% | - |
| Price % | 10.0% | 3.8% | 0.3% | (1.1)% | (0.4)% |
| Mix % | (1.7)% | (0.7)% | (0.4)% | (0.2)% | (0.3)% |
| Organic growth % | 9.1% | 8.1% | 0.1% | (1.5)% | (0.7)% |
1.) Quarters correspond to financial periods aligned with calendar year (based on pro-forma information)

| Q3 20221). | Q4 20221). | Q1 20231). | Q2 20231). | H1 FY231). | |
|---|---|---|---|---|---|
| ARYZTA Europe | |||||
| Volume % | 4.0% | 5.7% | 7.9% | 0.2% | 3.7% |
| Price % | 16.4% | 21.5% | 21.2% | 17.7% | 19.3% |
| Mix % | 0.1% | 0.2% | 0.2% | (0.4)% | (0.1)% |
| Organic growth % | 20.5% | 27.4% | 29.3% | 17.5% | 22.9% |
| ARYZTA Rest of World | |||||
| Volume % | 11.7% | 8.5% | - | (0.7)% | (0.3)% |
| Price % | 7.5% | 11.9% | 16.2% | 14.6% | 15.4% |
| Mix % | 1.6% | - | 2.1% | (0.4)% | 0.7% |
| Organic growth % | 20.8% | 20.4% | 18.3% | 13.5% | 15.8% |
| Total Group | |||||
| Volume % | 5.1% | 6.1% | 6.9% | 0.1% | 3.2% |
| Price % | 15.1% | 20.2% | 20.5% | 17.3% | 18.8% |
| Mix % | 0.3% | 0.2% | 0.5% | (0.4)% | - |
| Organic growth % | 20.5% | 26.5% | 27.9% | 17.0% | 22.0% |
1.) Quarters correspond to financial periods aligned with calendar year (based on pro-forma information). H1 FY23 represents 6-month financial period ended June 2023.

| Average | Average | Closing | Closing | |||
|---|---|---|---|---|---|---|
| Currency | H1 FY24 | H1 FY231). | % Change | H1 FY24 | FY23 | % Change |
| CHF | 0.9612 | 0.9859 | 2.5% | 0.9617 | 0.9332 | (3.1%) |
| AUD | 1.6420 | 1.5964 | (2.9%) | 1.6117 | 1.6185 | 0.4% |
| GBP | 0.8548 | 0.8772 | 2.6% | 0.8463 | 0.8688 | 2.6% |
| PLN | 4.3172 | 4.6334 | 6.8% | 4.3137 | 4.3382 | 0.6% |

'Organic growth' – represents the revenue growth during the period, after removing the impact of acquisitions and divestures and foreign exchange translation. This provides a "like-for-like" comparison with the previous period in constant scope and constant currency.
'EBITDA' – presented as earnings before interest, taxation, depreciation and amortisation.
'Free cash flow' – represents the company's ability to generate free funds from its operating activities after its investments in fixed assets and repayments of lease liabilities. It is calculated as net cash flows from operating activities per the IFRS cash flow statement, adjusted for cash flows related to the purchase of property, plant and equipment and intangible assets, proceeds from sale of property plant and equipment, lease principal payments and dividends paid on hybrid instruments.
'Net debt' – is defined as the Group's interest bearing loans and bonds and lease liabilities, after deduction of cash and cash equivalents.
'Hybrid instrument' – presented as Perpetual Callable Subordinated Instruments, which have no contractual maturity date and for which the Group controls the timing of settlement; therefore, these instruments are accounted for as equity instruments in accordance with IAS 32 'Financial Instruments'.
'Invested capital' – Excludes financial assets at fair value, bank debt, cash and cash equivalents and tax balances. Invested capital is a measure of the operational net assets used to generate the results of the business, excluding financing, tax and cash-management activities.
'NOPAT' – Net operating profit after tax. This is operating profit after a normalised tax rate of 25%, before gains/losses on disposal of businesses excluding taxation directly attributable to disposal of businesses.
'ROIC' – Return On Invested Capital is a measure of performance which integrates both measures of profitability and measures of capital efficiency. This is calculated as trailing twelve month NOPAT divided by average Invested capital, as at the beginning and the end of the financial period.
Please refer to Alternative Performance Measures on pages 28 - 30 of the Interim Report June 2024 for reconciliations.

Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.